The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
Code | Title | |
---|---|---|
H01AX01 | Pegvisomant |
Active Ingredient | Description | |
---|---|---|
Pegvisomant |
Pegvisomant is an analogue of human growth hormone that has been genetically modified to be a growth hormone receptor antagonist for the treatment of adult patients with acromegaly. Pegvisomant is highly selective for the GH receptor, and does not cross-react with other cytokine receptors, including prolactin. |
Title | Information Source | Document Type | |
---|---|---|---|
SOMAVERT Powder and solvent for solution for injection | European Medicines Agency (EU) | MPI, EU: SmPC |